Omalizumab for COPD with Allergies
Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD
This project is testing if a medication called omalizumab can help people with COPD who also have allergies to common indoor triggers.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11170528 on NIH RePORTER |
What this research studies
COPD affects everyone differently, and doctors are looking for ways to tailor treatments to each person. We know that many people with COPD also have allergies, and this combination might lead to worse health problems. This project will give omalizumab, a medicine already used for allergic asthma, to people with COPD who are allergic to common indoor allergens and exposed to them. We hope to see if this targeted approach can improve their health.
Who could benefit from this research
Good fit: Ideal candidates are adults aged 21 and older with COPD who have known allergies to common indoor allergens and are exposed to them.
Not a fit: Patients with COPD who do not have allergic sensitization or exposure to indoor allergens may not receive benefit from this specific treatment approach.
Why it matters
Potential benefit: If successful, this could offer a new, personalized treatment option for people with COPD who also experience allergies, potentially reducing their risk of severe health issues.
How similar studies have performed: Omalizumab has shown significant benefit for individuals with allergic asthma who have similar allergic sensitization and exposure, suggesting a promising approach for COPD.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Putcha, Nirupama — Johns Hopkins University
- Study coordinator: Putcha, Nirupama
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.